DE MONITOR - De Pharming Expert schreef op 27 augustus 2021 11:42:
[...]
KOMPLETE aims to enroll 48 people with HAE, and at least three attacks over an eight-week run-in period,
across more than 30 sites in 13 countries. Participants will be randomly assigned to one of three doses of KVD824 (300, 600, or 900 mg), or to a placebo, given twice daily for 12 weeks (about three months).
Dat zet tenminste zoden aan de dijk en kan wel eens snel gaan.